Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

eHealth (EHTH) Research & Development (2016 - 2025)

eHealth has reported Research & Development over the past 14 years, most recently at $12.6 million for Q1 2025.

  • Quarterly results put Research & Development at $12.6 million for Q1 2025, down 5.29% from a year ago — trailing twelve months through Mar 2025 was $69.5 million (down 1.1% YoY), and the annual figure for FY2025 was $51.8 million, down 3.16%.
  • Research & Development for Q1 2025 was $12.6 million at eHealth, down from $13.3 million in the prior quarter.
  • Over the last five years, Research & Development for EHTH hit a ceiling of $23.2 million in Q1 2021 and a floor of $12.6 million in Q1 2025.
  • Median Research & Development over the past 3 years was $16.9 million (2021), compared with a mean of $17.4 million.
  • Biggest five-year swings in Research & Development: soared 53.02% in 2021 and later fell 5.29% in 2025.
  • eHealth's Research & Development stood at $20.5 million in 2021, then crashed by 34.98% to $13.3 million in 2024, then decreased by 5.29% to $12.6 million in 2025.
  • The last three reported values for Research & Development were $12.6 million (Q1 2025), $13.3 million (Q1 2024), and $20.5 million (Q2 2021) per Business Quant data.